Q4/2024 12/31/2024 EPS 0.040 ZacksConsensus -0.060 ActVsEst 0.100 - Beat

Health Catalyst, Inc - Common stock (HCAT)
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm
Check Earnings Report
Company Research
Source: Wall Street Horizon

Impact Snapshot
Event Time:
HCAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCAT alerts
High impacting Health Catalyst, Inc - Common stock news events
Weekly update
A roundup of the hottest topics
HCAT
News
- Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025GlobeNewswire
- Health Catalyst, Inc. (NASDAQ: HCAT) had its price target lowered by analysts at KeyCorp from $7.00 to $5.00. They now have an "overweight" rating on the stock.MarketBeat
- Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™PR Newswire
- Health Catalyst, Inc. (NASDAQ: HCAT) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating.MarketBeat
- Health Catalyst, Inc. (NASDAQ: HCAT) had its "in-line" rating re-affirmed by analysts at Evercore ISI. They now have a $4.00 price target on the stock, down previously from $6.00.MarketBeat
HCAT
Earnings
- 2/26/25 - Beat
HCAT
Sec Filings
- 4/17/25 - Form SCHEDULE
- 4/7/25 - Form 4
- 4/3/25 - Form 144
- HCAT's page on the SEC website